Ruxolitinib News
Ruxolitinib currently has 0 news articles, with 10 predicted indications.
This page combines the AI-predicted indications for Ruxolitinib with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Predicted indications (10):
- uterine corpus perivascular epithelioid cell tumor (99.7%)
- benign PEComa (99.7%)
- lymphangiomyoma (99.7%)
- lymphangioleiomyomatosis (99.6%)
- liposarcoma (99.5%)
- familial rhabdoid tumor (99.5%)
- lung PEComa (99.4%)
- ovarian myxoid liposarcoma (99.4%)
- hemophagocytic syndrome associated with an infection (99.3%)
- acquired hemophagocytic lymphohistiocytosis associated with malignant disease (99.3%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.